{
  "buildId": "5lGULuFSFhUrfWgBpMJq_",
  "gssp": true,
  "isFallback": false,
  "page": "/calc/[...slug]",
  "props": {
    "__N_SSP": true,
    "pageProps": {
      "calc": {
        "before_use": "",
        "calc_type": "calculator",
        "chief_complaint_en": [
          "Flank Pain",
          "Hematuria"
        ],
        "cme_status": "",
        "content": {
          "about": {
            "evidence_based_medicine_en": "",
            "formula_en": "<p>Addition of the selected points:</p> <p><strong>Localized disease (Any T, N0M0)</strong></p> <table> <tbody> <tr> <td> <p><strong>T stage</strong></p> </td> <td> <p><strong><calculator id='3012'>Nuclear grade</calculator></strong></p> </td> <td> <p><strong><calculator id='3170'>ECOG PS</calculator></strong></p> </td> <td> <p><strong>Risk</strong></p> </td> </tr> <tr> <td rowspan=\"3\"> <p>T1</p> </td> <td rowspan=\"2\"> <p>Fuhrman 1-2</p> </td> <td> <p>0</p> </td> <td> <p>Low</p> </td> </tr> <tr> <td> <p>≥1</p> </td> <td rowspan=\"6\"> <p>Intermediate</p> </td> </tr> <tr> <td> <p>Fuhrman 3-4</p> </td> <td> <p>Any</p> </td> </tr> <tr> <td> <p>T2</p> </td> <td> <p>Any</p> </td> <td> <p>Any</p> </td> </tr> <tr> <td rowspan=\"4\"> <p>T3</p> </td> <td rowspan=\"2\"> <p>Fuhrman 1</p> </td> <td> <p>0</p> </td> </tr> <tr> <td> <p>≥1</p> </td> </tr> <tr> <td rowspan=\"2\"> <p>Fuhrman &gt;1</p> </td> <td> <p>0</p> </td> </tr> <tr> <td> <p>≥1</p> </td> <td> <p>High</p> </td> </tr> </tbody> </table> <p><strong><br>Metastatic disease (N1, N2, or M1)</strong></p> <table> <tbody> <tr> <td> <p><strong>N/M stage</strong></p> </td> <td> <p><strong><calculator id='3012'>Nuclear grade</calculator></strong></p> </td> <td> <p><strong><calculator id='3170'>ECOG PS</calculator></strong></p> </td> <td> <p><strong>Risk</strong></p> </td> </tr> <tr> <td> <p>N1M0</p> </td> <td> <p>Any</p> </td> <td> <p>Any</p> </td> <td> <p>Low</p> </td> </tr> <tr> <td rowspan=\"7\"> <p>N2M0/M1</p> </td> <td rowspan=\"2\"> <p>Fuhrman 1</p> </td> <td> <p>0</p> </td> <td> <p>Low</p> </td> </tr> <tr> <td> <p>≥1</p> </td> <td> <p>Intermediate</p> </td> </tr> <tr> <td rowspan=\"2\"> <p>Fuhrman 2</p> </td> <td> <p>0</p> </td> <td> <p>Low</p> </td> </tr> <tr> <td> <p>≥1</p> </td> <td rowspan=\"3\"> <p>Intermediate</p> </td> </tr> <tr> <td> <p>Fuhrman 3</p> </td> <td> <p>Any</p> </td> </tr> <tr> <td rowspan=\"2\"> <p>Fuhrman 4</p> </td> <td> <p>0</p> </td> </tr> <tr> <td> <p>≥1</p> </td> <td> <p>High</p> </td> </tr> </tbody> </table> <p>&nbsp;</p>",
            "more_info_en": "<div class='table-responsive'> <table class='table table-bordered table-hover'> <tbody> <tr> <th>Disease Type</th> <th>Risk Group</th> <th>Five-year disease-specific survival</th> </tr> <tr> <td rowspan='3'>Local Disease</td> <td>Low</td> <td>91.1%</td> </tr> <tr> <td>Intermediate</td> <td>80.4%</td> </tr> <tr> <td>High</td> <td>54.7%</td> </tr> <tr> <td rowspan='3'>Metastatic Disease</td> <td>Low</td> <td>32%</td> </tr> <tr> <td>Intermediate</td> <td>19.5%</td> </tr> <tr> <td>High</td> <td>0%</td> </tr> </tbody> </table> </div>",
            "references_list": {
              "Clinical Practice Guidelines": [
                {
                  "href": "",
                  "text": ""
                }
              ],
              "Manufacturer Website": [
                {
                  "href": "",
                  "text": ""
                }
              ],
              "Original/Primary Reference": [
                {
                  "href": "http://www.ncbi.nlm.nih.gov/pubmed/12454113",
                  "text": "Zisman A,Pantuck AJ,Wieder J, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol. 2002; 20: 4559–4566."
                }
              ],
              "Other References": [
                {
                  "href": "http://annonc.oxfordjournals.org/content/23/suppl_7/vii65.full",
                  "text": "Escudier B, Eisen T, Porta C, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2012; 23(suppl 7):vii65–vii71."
                }
              ],
              "Outcomes": [
                {
                  "href": "",
                  "text": ""
                }
              ],
              "Validation": [
                {
                  "href": "http://jco.ascopubs.org/content/22/16/3316.abstract?ijkey=a1a6e4e6960a768fd1f4bfbde97f0aae0810e1ca&keytype2=tf_ipsecsha",
                  "text": "Patard J, et al. Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study. JCO Aug 15, 2004:3316-3322"
                }
              ]
            }
          },
          "contributor": {
            "expert_name": []
          },
          "creator": [
            {
              "name": "Dr. Amnon Zisman"
            }
          ],
          "how_to_use": {
            "pearls_pitfalls_en": "<ul> <li>This score placed patients with local or metastatic renal cell carcinoma (mRCC) into mortality risk groups: low, intermediate/moderate, and high.</li> <li>The derivation and numerous external validations have been chart reviews, though all find orderly progressions in 5-year survival based on group.</li> <li>Prospective validation is eagerly awaited, and we know of no validations including substantial numbers of patients treated with modern targeted VEGF therapy.</li> </ul>",
            "use_case_en": "<p>Patients with RCC, localized or metastatic, particularly those being considered for clinical trial enrollment.</p>",
            "why_use_en": "<p>There are no validated scoring systems for predicting survival in mRCC. Using a score may help sketch categories of survival time better than clinical judgment alone.</p>"
          },
          "next_steps": {
            "advice_en": "<p>The UISS score is often used for screening and stratifying patients into modern therapy trials, including trials of VEGF therapy such as SUNItinib. The consistency of results in validation studies is somewhat reassuring, and one advantage is its applicability to patients with and without metastatic disease.</p>",
            "critical_actions_en": "<p>The UISS score is complex, requiring close attention to multiple variables for correct classification.</p>",
            "management_en": "<ul>\n<li>We are unaware of validated management algorithms using the score.</li>\n<li>Refer to&nbsp;<guideline id=\"10121\">AUA guidelines</guideline>&nbsp;for management of renal cancer.</li>\n</ul>"
          },
          "related_resources": {
            "guidelines": [
              {
                "description": "Guideline from AUA",
                "link": "https://www.mdcalc.com/guidelines/other/renal-mass-localized-renal-cancer",
                "society": "American Urological Association",
                "text": "Renal Mass and Localized Renal Cancer"
              }
            ],
            "interests": [
              {
                "link": "https://www.mdcalc.com/rcc-renal-cell-carcinoma-practice-pearls",
                "text": "Practice Pearls: Renal Cell Carcinoma"
              }
            ],
            "mdcalc_rating": {
              "clinical": "",
              "evidence": "",
              "popularity": ""
            },
            "partner_contact": [],
            "sdm_tool": [],
            "teaching": [],
            "videos": []
          },
          "reviewer": []
        },
        "disease_en": [
          "Renal Cell Carcinoma"
        ],
        "dosing": false,
        "equation_logic": "1ca413fbf0c3917a7facbeb3dd4d7789",
        "equation_logic_text": "var t = t || 0\nvar n = n || 0\nvar m = m || 0\n\nvar calc_output = [];\nvar disease = parseInt(disease);\nt = parseInt(t);\nn = parseInt(n);\nm = parseInt(m);\nvar fuhrman = parseInt(fuhrman);\nvar ecog = parseInt(ecog);\nvar survstring = ' Five Year survival';\nvar value = '';\nvar msg = '';\nvar u;\n\nif (disease == 1) {\n    u = t + fuhrman + ecog;\n} else if (disease == 2) {\n    u = n + m + fuhrman + ecog;\n}\n\nif (disease == 1) {\n    if (t == 1 && fuhrman <= 2 && ecog == 0) {\n        value = '91.1%';\n        msg = 'Low Risk';\n    } else if (t == 1 && fuhrman <= 2 && ecog == 1) {\n        value = '80.4%';\n        msg = 'Moderate Risk';\n    } else if (t == 1 && fuhrman > 1 && fuhrman <= 4 && ecog >= 0) {\n        value = '80.4%';\n        msg = 'Moderate Risk';\n    } else if (t == 2) {\n        value = '80.4%';\n        msg = 'Moderate Risk';\n    } else if (t == 3 && fuhrman == 1 && ecog >= 0) {\n        value = '80.4%';\n        msg = 'Moderate Risk';\n    } else if (t == 3 && fuhrman > 1 && ecog == 0) {\n        value = '80.4%';\n        msg = 'Moderate Risk';\n    } else if (t == 3 && fuhrman > 1 && ecog >= 1) {\n        value = '54.7%';\n        msg = 'High Risk';\n    } else if (t == 4) {\n        value = '54.7%';\n        msg = 'High Risk';\n    } \n}\nelse if (disease == 2) {\n    if (n == 1 && m == 0 && fuhrman > 0 && ecog >= 0) {\n        value = '32%';\n        msg = 'Low Risk';\n    } else if (n == 2 && m >= 0 && fuhrman >= 1 && fuhrman <= 2 && ecog == 0) {\n        value = '32%';\n        msg = 'Low Risk';\n    } else if (n == 2 && m >= 0 && fuhrman >= 1 && fuhrman <= 2 && ecog == 1) {\n        value = '19.5%';\n        msg = 'Moderate Risk';\n    } else if (n == 1 && m >= 0 && fuhrman >= 1 && fuhrman <= 2 && ecog >= 0) {\n        value = '19.5%';\n        msg = 'Moderate Risk';\n    } else if (n == 1 && m >= 0 && fuhrman >= 3 && fuhrman <= 4 && ecog >= 0) {\n        value = '19.5%';\n        msg = 'Moderate Risk';\n    } else if (n == 2 && m >= 0 && fuhrman == 3 && ecog >= 0) {\n        value = '19.5%';\n        msg = 'Moderate Risk';\n    } else if (n == 2 && m >= 0 && fuhrman == 4 && ecog == 0) {\n        value = '19.5%';\n        msg = 'Moderate Risk';\n    } else if (n == 2 && m >= 0 && fuhrman == 4 && ecog == 1) {\n        value = '0%';\n        msg = 'High Risk';\n    }\n}\n\ncalc_output.push({ name: 'mini', value: msg, value_text: ' ', message: ' ' });\ncalc_output.push({ name: 'UISS', value: msg, value_text: ' ', message: value + survstring + '<br/><br/><guideline id = \"10121\">AUA guideline</guideline>' });",
        "favorite_id": 3009,
        "full_title_en": "UCLA Integrated Staging System (UISS) for Renal Cell Carcinoma (RCC)",
        "input_schema": [
          {
            "conditionality": "",
            "label_en": "Type of disease present",
            "name": "disease",
            "optional": false,
            "options": [
              {
                "label": "Metastatic",
                "value": 2
              },
              {
                "label": "Localized",
                "value": 1
              }
            ],
            "show_points": false,
            "type": "toggle"
          },
          {
            "subheading": "UISS Criteria",
            "subheading_instructions": "",
            "type": "subheading"
          },
          {
            "conditionality": "disease == 1",
            "label_en": "Localized disease - T stage",
            "name": "t",
            "optional": false,
            "options": [
              {
                "label": "T1",
                "value": 1
              },
              {
                "label": "T2",
                "value": 2
              },
              {
                "label": "T3",
                "value": 3
              },
              {
                "label": "T4",
                "value": 4
              }
            ],
            "show_points": false,
            "type": "radio"
          },
          {
            "conditionality": "disease == 2",
            "label_en": "Metastatic disease - N stage",
            "name": "n",
            "optional": false,
            "options": [
              {
                "label": "N1",
                "value": 1
              },
              {
                "label": "N2",
                "value": 2
              }
            ],
            "show_points": false,
            "type": "radio"
          },
          {
            "conditionality": "disease == 2",
            "label_en": "Metastatic disease - M stage",
            "name": "m",
            "optional": false,
            "options": [
              {
                "label": "M0",
                "value": 0
              },
              {
                "label": "M1",
                "value": 1
              }
            ],
            "show_points": false,
            "type": "radio"
          },
          {
            "conditionality": "",
            "label_en": "<calculator id='3012'>Fuhrman nuclear grade</calculator>",
            "name": "fuhrman",
            "optional": false,
            "options": [
              {
                "label": "I",
                "value": 1
              },
              {
                "label": "II",
                "value": 2
              },
              {
                "label": "III",
                "value": 3
              },
              {
                "label": "IV",
                "value": 4
              }
            ],
            "show_points": false,
            "type": "radio"
          },
          {
            "conditionality": "",
            "label_en": "<calculator id='3170'>ECOG Performance Status</calculator>",
            "name": "ecog",
            "optional": false,
            "options": [
              {
                "label": "0",
                "value": 0
              },
              {
                "label": "≥1",
                "value": 1
              }
            ],
            "show_points": false,
            "type": "radio"
          }
        ],
        "instructions_en": "<ul> <li>Localized: Any T; N0; M0</li> <li>Metastatic: T>0; N>1; M>1</li> <li>For accurate staging, see the <calculator id='3011'> TNM Staging for RCC calculator</a></li></ul>",
        "md5": "822adfbc348175af5eeb230bb7070d24",
        "medium_description_en": "<p>Provides 5-year disease-free prognosis for localized and metastatic RCC.</p>",
        "purpose_en": [
          "Prognosis"
        ],
        "search_abbreviation_en": [
          "UCLA",
          "RCC",
          "localized",
          "mets",
          "metastatic",
          "UISS"
        ],
        "search_id": "c-3009",
        "seo": {
          "keywords_en": "ucla, ucla score, rcc score, uiss score, ucla uiss score, rcc prognosis, ucla cancer score, ucla cancer prognosis, ucla rcc score, renal cell carcinoma score, ucla kidney cancer, kidney cancer score, metastatic rcc, localized rcc, tnm rcc, tnm ucla, tnm UISS, UCLA UISS",
          "meta_description_en": "UCLA Integrated Staging System (UISS) for Renal Cell Carcinoma (RCC) provides 5-year disease-free prognosis for localized and metastatic RCC."
        },
        "short_description_en": "5 year prognosis for RCC.",
        "short_title_en": "UISS for RCC",
        "slug": "ucla-integrated-staging-system-uiss-renal-cell-carcinoma-rcc",
        "specialty_en": [
          "Hematology and Oncology",
          "Hospitalist Medicine",
          "Internal Medicine",
          "Nephrology",
          "Urology"
        ],
        "system_en": [
          "Oncologic",
          "Renal",
          "Urinary"
        ]
      },
      "contributors": [],
      "creators": [
        {
          "about_en": "<p>Amnon Zisman, MD, is professor of urologic surgery at Sackler School of Medicine affiliated Tel Aviv University. He is currently head of urology department at Assaf Harofeh Medical Center. Dr. Zisman’s research focuses on increased accuracy of diagnosis and prognosis of RCC as well as novel treatment strategies in renal disease.</p>",
          "deceased": false,
          "description": "",
          "firstName": "",
          "img": "",
          "lastName": "",
          "name": "Dr. Amnon Zisman",
          "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-amnon-zisman.jpeg",
          "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Zisman+A%5BAuthor%5D",
          "signedCOI": false
        }
      ],
      "envs": {
        "CANONICAL_URL_ROOT": "https://www.mdcalc.com",
        "CONTENT_SERVER_TAG": "WEB_PROD",
        "RECAPTCHA_PUBLIC_KEY": "6Lcu1mMkAAAAAAwmSDO3I7JNaUo9YtZ3jnrzTP6a",
        "STRIPE_PUB_KEY": "pk_live_yYm2UzDzaudhFgqWcKbv9vH7"
      },
      "faqs": [
        {
          "cme_faq": {
            "answer": "<p>MDCalc&rsquo;s Continuing Medical Education (CME) service allows users to easily earn AMA PRA Category 1 CreditsTM through regular use of MDCalc. Simply put, on top of getting the best medical calculators in the world, your usage will help you achieve your annual CME requirements, including specialty CME, without any extra effort.</p>",
            "question": "What is MDCalc CME?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Yes, in support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MDCalc Ltd. Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p>",
            "question": "Is MDCalc CME accredited?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Only United States attending physicians, nurse practitioners, nurses, and physician assistants are eligible for our CME service.</p>",
            "question": "Who can enroll and how?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>We have over 275 CME-eligible calculators across various specialties. You can read the clinical content supporting any CME calculators to start earning. Once you have viewed all the supporting content for a calculator, you will have officially earned the credit amount (0.5 credits) and will be able to redeem a certificate. For now, only calc content in CME-eligible calcs is eligible for CME credits, however, we&rsquo;ll be expanding our CME service to include more of our content in the future.</p>",
            "question": "What activities can I do to earn CME credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Simply use our search bar or visit our homepage to easily find CME-eligible calcs. You must be enrolled in our CME service to see which calcs are CME-eligible.</p>",
            "question": "Where can I find calcs with which I can earn credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Once you&rsquo;ve enrolled in our CME service, you will have a personal CME Dashboard where you can view all of your earned credits. You can navigate to the dashboard by clicking the CME button in the header at the top of any page.</p>",
            "question": "Where can I see which credits I’ve earned?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Go to your CME Dashboard and select the credits you&rsquo;d like to redeem, fill out a few dropdown answers about how you used the calc, and then proceed to checkout.</p>",
            "question": "How do I redeem CME credits?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>No. Earning credits as you use calcs is free, but either you (or your employer) will need to purchase an annual subscription to redeem your CME certificates.</p>",
            "question": "Are CME credits free?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Just like with earned credits, you can view your CME certificates on your CME Dashboard in the &ldquo;CME Certificates&rdquo; tab. Certificates include a list of all of the calcs for which CME was earned along with a tally of the specialty CME.</p>",
            "question": "Where can I see my CME certificates?",
            "type": "Using"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>One year from the date of purchase.</p>",
            "question": "How long do credits in an annual subscription last?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>General; Addiction and Controlled Substances; Cardiac Care; Domestic and Intimate Partner Violence; Geriatrics; HIV and Infectious Disease; Hospice, End-of-Life, Terminal Illness, and Palliative Care; Mental and Behavioral Health; Pain Management; Pediatrics; Stroke; and Trauma.</p>",
            "question": "What specialty CME credits are included in the plan?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Your gift card will be sent via email within 1-2 business days of making your purchase. You will be able to select from the following options - Visa, Amazon.com, Apple. Be sure to claim your gift card offer within 90 days of receiving the email.</p>\n<p>Your CME purchase may have implications for tax reporting purposes. The cost of your CME product may or may not be tax-deductible when used for professional purposes. Any reimbursed amount for incentives must be declared as personal income for tax purposes. Please consult your tax advisor. MDCalc does not provide tax advice.</p>",
            "question": "I ordered a CME package with a gift card. How does it work?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Per the new guidelines from ACCME, the receipt will separate the cost you paid into the cost of the gift card and the cost of the CME learning activity.</p>",
            "question": "What will show on my receipt for CME when it includes a gift card?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can get a refund (minus any promotional gift amount) within 30-days if the ease of earning and redeeming does not meet your expectations and if you have redeemed no more than 4 credits. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request a refund.</p>",
            "question": "How do I get a refund if I'm not satisfied?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can upgrade your subscription throughout your billing cycle and pay the difference for a higher plan. You may request to downgrade your plan to a lower level to coincide with your next renewal. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request changes.</p>",
            "question": "How do I later upgrade to a different plan if I need more credits?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Gift card plans are available for 1 year and do not auto-renew. Standard, non gift-card subscriptions are auto-renewed annually. You can disable the automatic renewal of your subscription at any time by emailing <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a>.</p>",
            "question": "Do CME plans auto-renew?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>If you&rsquo;re part of a team or practice that wants to sign up five or more physicians, please email us at <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> for more information.</p>",
            "question": "How do I get information on a discounted bulk subscription program for my institution, team, or practice?",
            "type": "Purchasing"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>On July 28, 2022, ACCME updated the guidelines regarding the use of high-value incentives. These guidelines allow for the use of gift card rewards in a regulated manner. Visit the ACCME website to read their guidelines.</p>",
            "question": "Did the ACCME decide to regulate gift cards?",
            "type": "Purchasing"
          }
        }
      ],
      "headConfig": {
        "canonicalUrl": "/calc/3009/ucla-integrated-staging-system-uiss-renal-cell-carcinoma-rcc",
        "description": "UCLA Integrated Staging System (UISS) for Renal Cell Carcinoma (RCC) provides 5-year disease-free prognosis for localized and metastatic RCC.",
        "keywords": "ucla, ucla score, rcc score, uiss score, ucla uiss score, rcc prognosis, ucla cancer score, ucla cancer prognosis, ucla rcc score, renal cell carcinoma score, ucla kidney cancer, kidney cancer score, metastatic rcc, localized rcc, tnm rcc, tnm ucla, tnm UISS, UCLA UISS",
        "title": "UCLA Integrated Staging System (UISS) for Renal Cell Carcinoma (RCC)"
      },
      "isCMECalc": false,
      "measurements": [],
      "relCalcs": [
        {
          "calcId": 3012,
          "short_title_en": "Fuhrman Nuclear Grade",
          "slug": "fuhrman-nuclear-grade-clear-cell-renal-carcinoma"
        },
        {
          "calcId": 3008,
          "short_title_en": "IMDC Model for mRCC",
          "slug": "imdc-international-metastatic-rcc-database-consortium-risk-model-metastatic-renal-cell-carcinoma"
        },
        {
          "calcId": 3007,
          "short_title_en": "Mekhail Extension",
          "slug": "mekhail-extension-motzer-score"
        }
      ],
      "societies": {
        "American Association for the Study of Liver Diseases": {
          "abbreviation": "AASLD",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.aasld.org/"
        },
        "American College Of Emergency Physicians": {
          "abbreviation": "ACEP",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/american-college-of-emergency-physicians-squarelogo.png",
          "web_link": "https://www.acep.org/"
        },
        "American College of Gastroenterology": {
          "abbreviation": "ACG",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/acg_logo.png",
          "web_link": "https://gi.org/"
        },
        "American College of Rheumatology": {
          "abbreviation": "ACR",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.rheumatology.org/"
        },
        "American Gastroenterological Association": {
          "abbreviation": "AGA",
          "description": "plain-text",
          "img": "https://apps.mdcalc.com/images/societies/aga.jpeg",
          "web_link": "https://gastro.org"
        },
        "American Heart Association": {
          "abbreviation": "AHA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/societies/+AHA+(American+Heart+Association).png",
          "target": "aha",
          "web_link": "http://www.heart.org/HEARTORG/"
        },
        "American Urological Association": {
          "abbreviation": "AUA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.auanet.org/"
        },
        "EB Medicine": {
          "abbreviation": "EB Medicine",
          "description": "EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.",
          "img": "https://cdn-web-img.mdcalc.com/other/eb_medicine-icon-only.jpg",
          "target": "eb-medicine",
          "web_link": "http://www.ebmedicine.net/"
        },
        "MDCalc CME": {
          "abbreviation": "MDCalc CME",
          "img": "https://cdn-web-img.mdcalc.com/Stroke-CME-content.jpg",
          "web_link": "https://www.mdcalc.com/stroke-cme?utm_source=NIHSS_calc&utm_medium=NIHSS_calc&utm_campaign=NIHSS_calc"
        },
        "OTHER": {
          "abbreviation": "OTHER"
        },
        "Postgraduate Institute for Medicine": {
          "abbreviation": "PIM",
          "description": "plain-text",
          "img": "https://cdn-web-img.mdcalc.com/PIM-circle-COLOR.jpeg",
          "target": "pim",
          "web_link": "https://www.pimed.com/"
        },
        "VACO Podcast": {
          "description": "Listen to the VACO co-creators break down how to use VACO\\, what it does\\, and what it doesn’t.",
          "img": "https://cdn-web-img.mdcalc.com/content/podcast 2.png",
          "web_link": "https://www.stimuluspodcast.com/post/32-the-covid-mortality-score-vaco"
        }
      },
      "validSections": [
        "whenToUseViewed",
        "pearlsPitfallsViewed",
        "whyUseViewed",
        "nextStepsViewed",
        "evidenceViewed"
      ]
    }
  },
  "query": {
    "slug": [
      "3009",
      "ucla-integrated-staging-system-uiss-renal-cell-carcinoma-rcc"
    ]
  },
  "scriptLoader": []
}